Loading...
A Recent Achievement In the Discovery and Development of Novel Targets for the Treatment of Type-2 Diabetes Mellitus
Type 2 diabetes (T2DM) is a chronic metabolic disorder. Impaired insulin secretion, enhanced hepatic glucose production, and suppressed peripheral glucose use are the main defects responsible for developing the disease. Besides, the pathophysiology of T2DM also includes enhanced glucagon secretion,...
Na minha lista:
| Udgivet i: | J Exp Pharmacol |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6959499/ https://ncbi.nlm.nih.gov/pubmed/32021494 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JEP.S226113 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|